Multidrug resistant Pseudomonas aeruginosa in Iran: A systematic review and metaanalysis

49Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: Multidrug-resistant Pseudomonas aeruginosa (MDR P. aeruginosa) is known as a serious threat to human health worldwide. Limited information is available concerning the prevalence of MDR P. aeruginosa in Iran. The aim of the present study was to investigate the relative frequency of MDR P. aeruginosa in different parts of Iran. Materials and Methods: Using appropriate keywords and well-known English and Persian database, available data about MDR P. aeruginosa in Iran were retrieved. After applying predefined criteria, relevant studies were selected. Results: By using random-effect models, the pooled incidence of MDR P. aeruginosa was estimated 58% (95% confidence interval [CI]; 0.54-0.61). The highest and lowest prevalence of MDR P. aeruginosa were observed in Tehran (100%) (95% CI; 0.94-1.00) and Zahedan (16%) (95% CI; 0.10-0.24), respectively. The highest resistance rate was against ceftazidime (50%) (95% CI; 0.46-0.54) and amikacin (50%) (95% CI; 0.46-0.54). Conclusion: Our findings are of concern since they demonstrate the high prevalence rate of MDR P. aeruginosa in the majority of Iranian hospitals.

Cite

CITATION STYLE

APA

Vaez, H., Salehi-Abargouei, A., Ghalehnoo, Z. R., & Khademi, F. (2018). Multidrug resistant Pseudomonas aeruginosa in Iran: A systematic review and metaanalysis. Journal of Global Infectious Diseases, 10(4), 212–217. https://doi.org/10.4103/jgid.jgid_113_17

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free